Literature DB >> 22225972

Posterior reversible encephalopathy syndrome and oral methotrexate.

Caroline Hart1, Michael O Kinney, Mark O McCarron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22225972     DOI： 10.1016/j.clineuro.2011.12.008

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN： 0303-8467            Impact factor:   1.876


× No keyword cloud information.
  6 in total

1.  Clinical reasoning: progressive visuospatial problems in a 71-year-old man.

Authors:  Mkael Symmonds; Wilhelm Küker; Ursula G Schulz
Journal:  Neurology       Date:  2014-07-01       Impact factor: 9.910

2.  Posterior reversible encephalopathy syndrome following elevated mean arterial pressures for cervical spinal cord injury.

Authors:  Jeffrey H Zimering; Addisu Mesfin
Journal:  J Spinal Cord Med       Date:  2016-12-05       Impact factor: 1.985

Review 3.  Neurological disorders and inflammatory bowel diseases.

Authors:  Giovanni Casella; Gian Eugenio Tontini; Gabrio Bassotti; Luca Pastorelli; Vincenzo Villanacci; Luisa Spina; Vittorio Baldini; Maurizio Vecchi
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

4.  Leukoencephalopathy due to oral methotrexate.

Authors:  I González-Suárez; M J Aguilar-Amat; M Trigueros; A M Borobia; A Cruz; J Arpa
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

Review 5.  Posterior reversible encephalopathy syndrome: a neurologic phenomenon in cancer patients.

Authors:  Eileen M Le; Monica E Loghin
Journal:  Curr Oncol Rep       Date:  2014-05       Impact factor: 5.075

6.  Posterior reversible encephalopathy syndrome in a postpartum woman with acute lymphoblastic leukaemia after intrathecal methotrexate.

Authors:  Craig Mescher; Arne Slungaard
Journal:  BMJ Case Rep       Date:  2017-10-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.